Otsuka Holdings Co., Ltd. (4578.T)

6.370,00 +98,00 (+1,56%) Alla chiusura: 03:15PM JST

Otsuka Holdings Co., Ltd.

2-9 Kanda-Tsukasamachi
Chiyoda-ku
Tokyo 101-0048
Japan
81 3 6717 1410
https://www.otsuka.com

Settore/i: Healthcare
Settore: Drug Manufacturers - General
Impiegati a tempo pieno: 34.388

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Tatsuo Higuchi	CEO, President & Representative Director	221M	N/D	1950
Mr. Makoto Inoue	COO & Representative Director	116M	N/D	1958
Mr. Yoshiro Matsuo	Executive Deputy President & Executive Director	94M	N/D	1960
Mr. Masayuki Kobayashi	Executive Director	113M	N/D	1966
Ms. Yuko Makino	CFO & Executive Director	N/D	N/D	1961
Akiko Ryu	Senior VP & Director of Human Resource Planning Department	N/D	N/D	N/D
Ms. Noriko Tojo	Executive Director	72M	N/D	1964
Mr. Shuichi Takagi	Executive Director	N/D	N/D	1966
Chiaki Sakurai	Senior Vice President of Nutraceutical Business, Global Strategy & Planning Headquarters	N/D	N/D	N/D
Shigeko Takahashi	Senior VP and GM of Nutraceutical Business, Global Strategy & Planning Headquarters	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in JPY.

Descrizione

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products. In addition, the company offers IT solution services; adhesive tapes; flaky titanate and compounds; IV solutions; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; urinary tract health products; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.

Governance aziendale

L'ISS Governance QualityScore di Otsuka Holdings Co., Ltd. al 1 aprile 2024 è 8. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 8; diritti degli azionisti: 10; retribuzione: 1.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.